Aggressive pulmonary adenocarcinoma with new FGFR translocation and cMET mutation not responsive to crizotinib and nintedanib treatment: a case report

The onset of routine use of the next generation sequencing (NGS) leads to discovery of new mutations in non-small cell lung cancer (NSCLC). In addition, comprehension of therapeutic potential of these genetic alterations in clinical practice is needed and required. Both, rare mutations and the thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Svaton, Martin, Vanecek, Tomas, Mukensnabl, Petr, Baxa, Jan, Krakorova, Gabriela, Blazek, Jiri, Pesek, Milos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797612/
https://www.ncbi.nlm.nih.gov/pubmed/35117560
http://dx.doi.org/10.21037/tcr.2019.12.85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797612/
https://www.ncbi.nlm.nih.gov/pubmed/35117560
http://dx.doi.org/10.21037/tcr.2019.12.85

Ejemplares similares